Expect Industry To Step Up Drug Pricing Self-Regulation In 2017 – PwC
Executive Summary
As industry begins to organize around broader self-regulation on drug pricing, PwC Partner Rick Judy expects pharma companies to announce more social contracts with consumers. Industry self-regulation on prices is one of 10 top health issues for 2017 identified by the consulting firm.